Literature DB >> 5321147

Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report.

O B Bush, M Sugimoto, Y Fujii, F A Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5321147     DOI： 10.1164/arrd.1965.92.5.732

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  8 in total

1.  Re-examining treatment of latent tuberculosis infection.

Authors:  B Lynn Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2001-07

Review 2.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

3.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 4.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

5.  Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

6.  Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry method in a randomised, crossover study.

Authors:  André Daher; Luciana Pitta; Tereza Santos; Draurio Barreira; Douglas Pinto
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-02       Impact factor: 2.743

7.  Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany.

Authors:  Christian Gutsfeld; Ioana D Olaru; Oliver Vollrath; Christoph Lange
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.

Authors:  Timothy R Sterling; Gibril Njie; Dominik Zenner; David L Cohn; Randall Reves; Amina Ahmed; Dick Menzies; C Robert Horsburgh; Charles M Crane; Marcos Burgos; Philip LoBue; Carla A Winston; Robert Belknap
Journal:  MMWR Recomm Rep       Date:  2020-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.